BET

Baldwin & Obenauf Scores a Trifecta of Tellys for Fortune 500 Clients

Retrieved on: 
Wednesday, May 31, 2023
Branded content, Media.Monks, BBC, RYOT, Dow Jones, PBS Digital Studios, BNO, Finance, Silver, Creativity, Indian Telly Awards, BET, Vimeo, ESPN Films, NASA, Adobe, Television, A&E Networks, Hearst Communications, FEMA, Verizon Communications, BMS, BBC World Service, Digital, 20th Digital Studio, Netflix, National Geographic Society, Complex Networks, PBS, Partizan, BritBox, Nickelodeon, Airbnb, The Walt Disney Company, Paramount

SOMERVILLE, N.J., May 31, 2023 /PRNewswire/ -- Baldwin & Obenauf, Inc. (BNO) announces that the creative agency won multiple awards in Branded Content categories for videos produced for three of its Fortune 500 clients in the record breaking 44th Annual Telly Awards. Mastercard: Tap on Phone earned a Silver Telly Award in the Financial Services/Banking category; and BMS: This is Where it Gets Interesting and Verizon: Retail Rockstars both earned Bronze among all Recruitment videos.

Key Points: 
  • SOMERVILLE, N.J., May 31, 2023 /PRNewswire/ -- Baldwin & Obenauf, Inc. (BNO) announces that the creative agency won multiple awards in Branded Content categories for videos produced for three of its Fortune 500 clients in the record breaking 44th Annual Telly Awards.
  • "Producing engaging video content is also creatively stimulating and fun for our team and our clients.
  • "The caliber of the work this season coming from creators such as BNO truly has reflected the theme of breaking out and standing out," said Tellys Executive Director Sabrina Dridje.
  • The full list of the 44th Annual Telly Awards winners can be found at www.tellyawards.com/winners .

Data from Across Incyte’s Oncology Portfolio Accepted for Presentation at the 2023 ASCO Annual Meeting and EHA2023 Hybrid Congress

Retrieved on: 
Thursday, May 25, 2023
Biotechnology, General Health, Pharmaceutical, Health, Safety, Refractory, Science, Translational research, Update, Myeloproliferative neoplasm, Myelodysplastic syndrome, ALK, Center for International Blood and Marrow Transplant Research, Activin and inhibin, DLBCL, European Hematology Association, Research, Polycythemia vera, Combination therapy, S110, Chronic lymphocytic leukemia, Abstract, Combination, Chronic myelogenous leukemia, Cytokine release syndrome, ALL, CRS, Relapse, OPTIC, Lymphoma, MOST, Cancer, Diffuse large B-cell lymphoma, Neoplasm, ALK2, Abstract (summary), CML, PV, ASCO, BET, American Society of Clinical Oncology, EHA, Annual general meeting, Anemia, Society, Pharmaceutical industry, Communications satellite, Allotransplantation, Hydroxycarbamide, Primary myelofibrosis, Patient

ET)

Key Points: 
  • ET)
    Phase 1b, Open-Label Study of Add-On Therapy with CK0804 in Participants with Myelofibrosis, with Suboptimal Response to Ruxolitinib (Abstract #TPS7087.
  • ET)1
    A Phase 1/2 Study of Retifanlimab (INCMGA00012, Anti–PD-1), INCAGN02385 (Anti–LAG-3), and INCAGN02390 (Anti–TIM-3) Combination Therapy in Patients (Pts) with Advanced Solid Tumors (Abstract #2599.
  • ET)
    Abstracts are available on the EHA2023 Congress platform and accessible for on-demand viewing until August 15, 2023.
  • ET)5
    For full session details and data presentation listings, please see the ASCO ( https://conferences.asco.org ) and EHA2023 ( https://ehaweb.org/congress ) online programs.

THE SPECIAL REPORT WITH AREVA MARTIN WINS BRONZE AND SILVER FOR PUBLIC SERVICE & ACTIVISM AND SOCIAL IMPACT FOR SOCIAL VIDEO SERIES IN THE 44th ANNUAL TELLY AWARDS

Retrieved on: 
Thursday, May 25, 2023
Indian Telly Awards, Social impact, Media.Monks, BBC, RYOT, Special Report (TV program), Dow Jones, PBS Digital Studios, Breaking news, The Oprah Winfrey Show, Silver, BET, Vimeo, Roe v. Wade, ESPN Films, NASA, Adobe, Television, The, A&E Networks, Hearst Communications, FEMA, Public service, BBC World Service, Digital, Digital studio, Netflix, National Geographic Society, Complex Networks, PBS, Partizan, Film industry, BritBox, Nickelodeon, Airbnb, The Walt Disney Company, Paramount

LOS ANGELES , May 25, 2023 /PRNewswire/ -- The Special Needs Network is excited to announce that  "The Special Report With Areva Martin" was awarded Bronze and Silver Social Video Series awards for Public Service & Activism and Social Impact in the record breaking 44th Annual Telly Awards.

Key Points: 
  • LOS ANGELES , May 25, 2023 /PRNewswire/ -- The Special Needs Network is excited to announce that  "The Special Report With Areva Martin" was awarded Bronze and Silver Social Video Series awards for Public Service & Activism and Social Impact in the record breaking 44th Annual Telly Awards.
  • The award-winning show takes a deeper look at today's social and economic issues.
  • "Everyone can find the news headlines," said Martin, "we at 'The Special Report' are invested in digging deeper to get closer to the root of the issues.
  • We're telling the stories that need to be told; ones that you won't find anywhere else.

Mytonomy Takes Home 10 Wins at the 44th Annual Telly Awards

Retrieved on: 
Thursday, May 25, 2023
Communication, Software as a service, Media.Monks, Evidence-based medicine, Education, PBS Digital Studios, Creativity, Indian Telly Awards, BET, Organ, NASA, IRB, Patient, FEMA, Confusion, Digital, Digital studio, Netflix, National Geographic Society, PBS, Television, BritBox, Airbnb, The Walt Disney Company, Paramount

BETHESDA, Md., May 25, 2023  /PRNewswire-PRWeb/ -- Mytonomy, Inc., a leading enterprise SaaS solution for video-based patient education and engagement, announced today that its evidence-based, microlearning patient education and engagement platform has received 10 prestigious honors at the 44th Annual Telly Awards. The Telly Awards recognize excellence in video and television across all screens and are judged by industry leaders from renowned video platforms, television networks, streaming services, and production companies.

Key Points: 
  • The Telly Awards recognize excellence in video and television across all screens and are judged by industry leaders from renowned video platforms, television networks, streaming services, and production companies.
  • "We are honored to be recognized with these Telly Awards, which reaffirm our commitment to delivering high-quality, impactful content.
  • The following Mytonomy videos have been recognized with the 2023 Telly Awards:
    How Do I Know If I Can Be a Kidney Donor?
  • - SILVER
    "Mytonomy's achievements at the Telly Awards underscore our dedication to transforming patient education and engagement through innovative video content.

BLACK GIRLS ROCK!® Creator Beverly Bond Introduces BLACK GIRLS BOND®

Retrieved on: 
Wednesday, May 24, 2023
FEST, Advertising, Bond, Music, Woman, Multimedia, BET, BGR, Movement, BLACK, Health, International Women's Strike, Sponsor (commercial), Social media, Nightclub, Toy, Television, Black

NEW YORK, May 24, 2023 /PRNewswire/ -- Renowned founder and CEO of BLACK GIRLS ROCK!®, Beverly Bond, heralds a new era with the grand unveiling of  BLACK GIRLS BOND®, an innovative daily digital publication curated for audacious, wellness-conscious, fashion-forward, stylish, enterprising women of color.

Key Points: 
  • As Bond nears the conclusion of her three-year development deal with Black Entertainment Television (BET), she is poised to catapult her illustrious BLACK GIRLS ROCK!
  • As we launch BLACK GIRLS BOND®, we're joining an escalating wave of voices that are magnifying the need for Black-owned and black women-owned media.
  • BLACK GIRLS BOND® is poised to provide advertisers with fully integrated 360-degree media solutions and has enlisted ad network and technology company Hero Media.
  • Visit blackgirlsbond.com and stay connected with BLACK GIRLS BOND® on social media to receive updates, stories, and exclusive event announcements:
    To learn more about BLACK GIRLS BOND visit: https://blackgirlsbond.com/about-us/
    For Sponsorship / advertising inquiries, contact: [email protected]
    View original content to download multimedia: https://www.prnewswire.com/news-releases/black-girls-rock-creator-beverl...

Former White House Staffers to Release New Book in September

Retrieved on: 
Tuesday, May 23, 2023
President Trump, Linda, First Step Act, Heart, White House, Factions in the Republican Party (United States), Privacy Office of the U.S. Department of Homeland Security, Reconstruction, Policy, United States Secretary of Housing and Urban Development, Historically black colleges and universities, Trump, Workforce, Opportunity zone, BET, History, Republican Party, CNN, White, Lincoln, Housing, SBA, Small business, Principle, Management, Amazon

WASHINGTON, May 23, 2023 /PRNewswire/ -- Former Small Business Administration Cabinet official Chris Pilkerton and former White House Director of Urban Policy Ja'Ron Smith today announced their upcoming book, Underserved: Harnessing the Principles of Lincoln's Vision for Reconstruction for Today's Forgotten Communities, will be released on September 5, 2023.

Key Points: 
  • The book will explore Lincoln's intentions for Reconstruction, how they came up short following Lincoln's death, and how those shortcomings continue to impact underserved communities to this day.
  • "This book is the culmination of years of work on behalf of underserved communities," said Pilkerton.
  • Their book gives an inside look into how the Trump White House achieved these wins and provides an actionable guide for policymakers looking to replicate those successes from a conservative perspective.
  • "I have my roots in an underserved community, so this book is especially near and dear to my heart," said Smith.

VYNE Therapeutics to Attend BIO International Convention

Retrieved on: 
Thursday, May 18, 2023
BIO, Boston Convention and Exhibition Center, Convention center, BET, Private law, Therapy, Biotechnology Innovation Organization, Fine chemical

BRIDGEWATER, N.J., May 18, 2023 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced that members of management will attend the Biotechnology Innovation Organization (BIO) International Convention, taking place June 5-8, 2023 at the Boston Convention & Exhibition Center in Boston, Massachusetts.

Key Points: 
  • BRIDGEWATER, N.J., May 18, 2023 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced that members of management will attend the Biotechnology Innovation Organization (BIO) International Convention, taking place June 5-8, 2023 at the Boston Convention & Exhibition Center in Boston, Massachusetts.
  • The Company will be attending the conference and participating in partnering meetings and 1-on-1 meetings with investors.
  • VYNE management will be available to review its pipeline of unique and proprietary bromodomain & extra-terminal (BET) domain inhibitors.

VYNE Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

Retrieved on: 
Thursday, May 11, 2023
Pharmacokinetics, BET, Pulmonary fibrosis, Patient, Hematology, Toxicology, Vitiligo, Therapy, IPF, Idiopathic pulmonary fibrosis, Safety, Tay, Pharmaceutical industry, IND

BRIDGEWATER, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced financial results for the three months ended March 31, 2023 and provided a business update.

Key Points: 
  • “During the first quarter, we generated important new clinical data for VYN201, demonstrating positive safety results and pharmacokinetic results in healthy volunteers.
  • Furthermore, there were no clinically relevant treatment emergent adverse events, abnormal clinical laboratory results, electrocardiogram findings or patient withdrawals from the study.
  • VYNE expects to report topline 16-week data for all three cohorts from the Phase 1b trial in the third quarter of 2023.
  • VYNE also obtained rights to several other BD2-selective BET inhibitor compounds with attractive molecular profiles that the Company may develop, at its discretion, in the future.

EQS-News: MorphoSys Highlights Potential of Its Mid- to Late-Stage Oncology Pipeline at 2023 ASCO and EHA Annual Meetings

Retrieved on: 
Thursday, May 11, 2023
Ruxolitinib, Partnership, Peripheral T-cell lymphoma, MorphoSys, European Hematology Association, Primary myelofibrosis, Half-life, American Society of Clinical Oncology, Bone marrow, Lenalidomide, Joint Planning and Development Office, FSE, Immunotherapy, ASCO, BET, Pancreatic serous cystadenoma, Intolerance, Cancer, Patient, Lymphoma, EHA, Annual general meeting, EZH2, EZH1, Society, Disease, Pharmaceutical industry, Medical imaging, Tafasitamab, Hydroxycarbamide

“The data we are presenting at ASCO and EHA showcase the breadth and depth of our mid- to late-stage pipeline.

Key Points: 
  • “The data we are presenting at ASCO and EHA showcase the breadth and depth of our mid- to late-stage pipeline.
  • Monjuvi in combination with lenalidomide was investigated in the Phase 2 L-MIND study in patients with relapsed or refractory diffuse large B-cell lymphoma.
  • The presentations on Monjuvi include:
    An e-publication at ASCO and EHA of a new five-year sub-group analysis from L-MIND.
  • At ASCO, preliminary results from the Phase 2 portion of the study evaluating tulmimetostat across multiple tumor types will be presented during a poster session.

CLINIQUE WELCOMES MARSAI MARTIN AS BRAND AMBASSADOR AND PARTNER PRODUCER

Retrieved on: 
Monday, May 8, 2023
Gen, Magic, Digital, Culture, Genius Products, Global Brands Group, Multimedia, History, Element, Social media, Photography, Generation Z, Clinique, BET, NAACP, Skin, Television, Distribution (marketing), Vogue

NEW YORK, May 8, 2023 /PRNewswire/ -- Clinique, the leading Prestige Dermatological skincare and makeup brand for over 50 years, announces actress, producer, and philanthropist Marsai Martin as its new Brand Ambassador and first-ever Partner Producer. Marsai joins the Clinique team to lend her personal vision to authentically support brand storytelling, photography, and more.

Key Points: 
  • NEW YORK, May 8, 2023 /PRNewswire/ -- Clinique, the leading Prestige Dermatological skincare and makeup brand for over 50 years, announces actress, producer, and philanthropist Marsai Martin as its new Brand Ambassador and first-ever Partner Producer.
  • Marsai joins the Clinique team to lend her personal vision to authentically support brand storytelling, photography, and more.
  • "We are thrilled to welcome Marsai as a Clinique Brand Ambassador and first-ever Partner Producer.
  • "I'm so excited to join Clinique as a Brand Ambassador and Partner Producer," says Marsai.